Researchers have observed a decline in industry-sponsored post-approval clinical trials since the Inflation Reduction Act (IRA) was passed.

Curative Insurance Company announced a new partnership with Two Chairs, a comprehensive, high-quality mental health care provider, to offer $0 copay and $0 deductible* in-network mental health care ...

BPOM announced that 2,000 participants in Indonesia will take part in the clinical trial of the TB vaccine supported by Bill ...

Operator: Greetings, and welcome to the Kamada First Quarter 2025 Earnings Conference Call. At this time, all participants ...

Q1 2025 Earnings Call Transcript May 13, 2025 NEXGEL, Inc. beats earnings expectations. Reported EPS is $-0.09, expectations ...

From individualised product recommendations to AI-driven skin analysis, the beauty and cosmetics industry is undergoing a ...

BiomX announced positive topline results of the phase 2 trial evaluating BX211 for the treatment of diabetic foot osteomyelitis (DFO)< ...

Corporate and Financial Updates In April 2025, Invivyd secured a $30 million non-dilutive term loan facility with Silicon Valley Bank, a division of First Citizens Bank, supporting balance sheet ...

IXHL Stock - Incannex Healthcare’s shares surged 876% after completing patient dosing in the Phase 2 trial of its oral sleep ...

Researchers at the National Institute of Technology (NIT), Rourkela have developed an effective upgrade to electrocardiography (ECG), one of the most commonly-used techniques to monitor heart activity ...

Getac Technology Corporation (Getac), a leading provider of rugged computing and mobile video solutions, today announced that ...

Rahway: Merck, known as MSD outside of the United States and Canada, has received the approval from the U.S. Food and Drug ...